Xeriant, Inc. (XERI) shareholders
Close on Oct 19, 2026Market cap $15.78MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of XERI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Williams Jones Wealth Management, LLC. | 150,288 | 0.01% | $2.07K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q3 2024 | 2 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2024 | 2 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2024 | 2 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2023 | 2 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2023 | 2 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Edward C. DeFeudis Director | Mar 24, 2022 | Sale(10b5-1 plan) | −75,000 | $0.12 | $9.00K | 2,667,130 |
| Edward C. DeFeudis Director | Mar 23, 2022 | Sale(10b5-1 plan) | −41,871 | $0.12 | $5.02K | 2,742,130 |
| Edward C. DeFeudis Director | Mar 22, 2022 | Sale(10b5-1 plan) | −50,000 | $0.12 | $6.00K | 2,784,001 |
| Edward C. DeFeudis Director | Mar 18, 2022 | Sale(10b5-1 plan) | −15,000 | $0.12 | $1.80K | 2,834,001 |
| Edward C. DeFeudis Director | Mar 15, 2022 | Sale(10b5-1 plan) | −75,000 | $0.12 | $9.00K | 2,849,001 |
| Edward C. DeFeudis Director | Mar 14, 2022 | Sale(10b5-1 plan) | −60,000 | $0.12 | $7.20K | 2,924,001 |
| Edward C. DeFeudis Director | Mar 10, 2022 | Sale(10b5-1 plan) | −15,999 | $0.12 | $1.92K | 2,984,001 |
| Brendan Macpherson Chief Executive Officer, Director, 10% owner | Dec 30, 2013 | Other | +1,000,000 | – | – | 1,000,000 |
| Brendan Macpherson Chief Executive Officer, Director, 10% owner | Dec 30, 2013 | Other | +400,000 | – | – | 400,000 |
| Macpherson Belinda Storelli Chief Creative Officer, Director, 10% owner | Dec 30, 2013 | Other | +1,000,000 | – | – | 1,000,000 |
| Macpherson Belinda Storelli Chief Creative Officer, Director, 10% owner | Dec 30, 2013 | Other | +400,000 | – | – | 400,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Xeriant's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?